Success Story: With Our Expert Guidance, NIW Approved for A Biomedical Engineering Researcher Without RFE In Over 8 Months
On March 20th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Associate in the Field of Biomedical Engineering (Approval Notice).
General Field: Biomedical Engineering
Position at the Time of Case Filing: Postdoctoral Associate
Approval Notice Date: March 20th, 2026
Processing Time: 8 months, 24 days (Premium Processing Upgrade Requested)
Case Summary:
We are pleased to share the NIW approval of a researcher working at the intersection of biomedical engineering, nanomedicine, and targeted therapeutic design. The client holds a Ph.D. and, at the time of filing, was conducting postdoctoral research in the United States while pursuing a long-term research path in biomedical engineering. His proposed endeavor was to continue engineering targeted nanotechnology-driven drug delivery systems to improve treatment efficacy for cancer, inflammation, and genetic disorders, with the goal of enhancing patient outcomes while minimizing side effects.
Rather than treating this as a case built on credentials alone, the petition showed why the client’s work matters in practical terms. Targeted drug delivery is important because conventional therapies often lose effectiveness through poor localization and systemic toxicity. The client’s research addressed that problem by developing nanoscale systems that improve precision, reduce off-target effects, and support more efficient treatment strategies in areas tied to precision medicine and broader public health needs.
A Research Record That Shows More Than Productivity
In support of the petition, we documented 17 peer-reviewed journal articles, including 4 first-authored and 1 co-first-authored publication, along with 362 citations. We also presented evidence of major funding support connected to the client’s work. These metrics were not presented as self-sufficient. Instead, they were used to show independent reliance on the client’s work, field-wide recognition of his methods, and outside confidence in the value of his research direction. The petition further emphasized that multiple papers ranked among the most highly cited in their field and publication years, which helped demonstrate influence in a more adjudicator-friendly way than raw citation totals alone.
How We Demonstrated the Client’s Significance
The petition connected the client’s publication record, citation history, funded research, and ongoing postdoctoral work to a coherent future plan. It also highlighted how other researchers had built on his findings in nanomedicine, prodrug design, and disease-targeting formulations. This made the case stronger because it showed not just scholarly activity, but a record of research that others were already using.
Recommendation Letters
The petition included 2 recommendation letters from experts in the field. These letters helped reinforce the originality of the client’s research, the practical importance of his contributions, and his strong positioning to continue advancing the proposed endeavor.
Approval and Outcome
By tying the client’s past achievements to a clearly defined future endeavor, we demonstrated that waiving the labor certification requirement would benefit the United States. We are proud to have supported this client in achieving I-140 NIW approval and look forward to his continued contributions to targeted therapeutic innovation.